Krill harvesting company Aker BioMarine made a profit in 2015 despite a lower turnover, indicating that Kjell Inge Rokke's nutraceutical gamble may be paying off.
Aker Biomarine reported earnings before interest, taxation, depreciation and amortization (EBITDA) of $25.7 million (€22.8 million) -- a margin of 24 percent.
Sales fell slightly to $105.1 million (€93.2 million).
The profit is the first in at least four years at the company, and cashflow from the operation was also positive -- a turnaround from the three prior years.
The
